General

Black Diamond Therapeutics (NASDAQ:BDTX) Rating Increased to Strong-Buy at Piper Sandler

Published On : 2025-11-20

Piper Sandler raised shares of Black Diamond Therapeutics to a “strong-buy” rating in a report on Monday.

#General

Discover more from Trend Teller

Subscribe to get the latest posts sent to your email.